JP2001072590A - Energy metabolism in motion by isoflavone derived from soybean - Google Patents

Energy metabolism in motion by isoflavone derived from soybean

Info

Publication number
JP2001072590A
JP2001072590A JP28583199A JP28583199A JP2001072590A JP 2001072590 A JP2001072590 A JP 2001072590A JP 28583199 A JP28583199 A JP 28583199A JP 28583199 A JP28583199 A JP 28583199A JP 2001072590 A JP2001072590 A JP 2001072590A
Authority
JP
Japan
Prior art keywords
isoflavone
soybean
derived
fat
glycogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP28583199A
Other languages
Japanese (ja)
Inventor
Kaneyoshi Kubota
金嘉 窪田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KURESSENDO CORP KK
Original Assignee
KURESSENDO CORP KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KURESSENDO CORP KK filed Critical KURESSENDO CORP KK
Priority to JP28583199A priority Critical patent/JP2001072590A/en
Publication of JP2001072590A publication Critical patent/JP2001072590A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PROBLEM TO BE SOLVED: To exhibit action mechanism which female hormone has, save glycogen in order to enhance durable locomotive power and promote fat metabolism by isoflavone derived from a specific plant and having a chemical structure similar to female hormone. SOLUTION: Glycogen in motion is saved and fat metabolism is promoted by isoflavone derived from soybean. Isoflavone derived from hypocotyl of the soybean containing phytoestrogen as an active ingredient is mixed with a well- known food, food ingredients, medicine carrier or vehicle by a well-known method to provide durable locomotive power-enhancing food. When the above isoflavone is orally ingested, desired effect can be exhibited without adverse effect by ingesting the isoflavone in an amount of about 40-500 mg/adult.day as an active ingredient in one to several portions per day.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、持久性運動能力向
上に対して、大豆由来のイソフラボンに注目した。この
イソフラボンは、化学構造が女性ホルモン(エストロゲ
ン)に類似している。この類似性を利用して、イソフラ
ボンの経口摂取により、女性ホルモンの有する作用機序
を発揮させ、持久性運動能力の向上に役立てる。
The present invention focuses on soybean-derived isoflavones for improving endurance athletic performance. This isoflavone is similar in chemical structure to the female hormone (estrogen). By taking advantage of this similarity, oral administration of isoflavones exerts the mechanism of action of female hormones, which is useful for improving endurance exercise performance.

【0002】[0002]

【従来の技術】現在に至まで、持久性運動時のグリコー
ゲン節約作用と脂肪代謝促進作用に対して、大豆由来の
イソフラボンを経口摂取させたという事実は確認されて
いない。持久性運動時のスポーツサプリメントとして
は、ビタミンB群が主流で、最近になって、L−カルニ
チンやω−3脂肪酸が注目を集めている。
2. Description of the Related Art To date, no fact has been confirmed that soybean-derived isoflavone was orally ingested for its glycogen-saving action and fat metabolism-promoting action during endurance exercise. As a sports supplement for endurance exercise, the vitamin B group is the mainstream, and recently, L-carnitine and ω-3 fatty acids have attracted attention.

【0003】[0003]

【発明が解決しようとする課題】持久性運動時には、男
女の区別なく脂肪がエネルギー源の中心となる。しか
し、その程度には差があり、女子の場合には男子に比べ
て脂肪をエネルギー源として利用する比率が高い。体重
あたりのエネルギー消費量がほぼ等しい運動をした場
合、その中に占める糖質:脂肪:蛋白質の比率は、男子
の場合で 47:49:3であったのに対して、女子の
場合では33:61:2であった。女子では脂肪に依存
する率が断然高いことがわかる。持久性運動時におい
て、女子が男子よりも優れた記録を出すことがある。女
子では脂肪のエネルギー化率が高いことが関与している
と考えられる。そのポイントは、脂肪のエネルギー化が
大きいと結果的にグリコーゲンの消費節約につながるこ
とがある。
During endurance exercise, fat is the main energy source regardless of gender. However, there is a difference in the degree, and girls use a higher percentage of fat as an energy source than boys. In the case of exercising with almost the same amount of energy consumption per body weight, the ratio of carbohydrate: fat: protein in the exercise was 47: 49: 3 for boys, but 33:49 for girls. : 61: 2. It turns out that the rate of dependence on fat is much higher in girls. During endurance exercises, girls may perform better than boys. It is thought that high energy conversion of fat is involved in girls. The point is that the high energy conversion of fats can result in a saving of glycogen consumption.

【0004】その理論を支持する証拠が、雄ラットにエ
ストロゲンを投与した実験でえられている。エストロゲ
ンを5日間皮下注射投与した後、3時間のトレッドミル
ランニングを負荷し、その間における肝臓と筋肉のグリ
コーゲン消費を経時的に検査した。その結果、エストロ
ゲン投与群では、運動中のグリコーゲン消費が顕著に少
ないことが確認された。このことは、運動中のエネルギ
ー源として脂肪が積極的に利用されたことを示唆してい
る。それを確認するするために、貯蔵脂肪(腎周囲脂肪
組織重量)、血中脂肪酸レベル、筋肉中の脂肪量を測定
した。その結果、エストロゲン投与により、貯蔵脂肪が
減少し、血中の脂肪酸レベルが上昇し、筋肉中の脂肪量
が増大していることが判った。エストロゲンによって脂
肪動員が活発化し、血中の脂肪酸を筋肉が積極的に取り
込んで脂肪として貯蔵したことを示している。筋肉中に
貯蔵された脂肪が、運動中に脂肪酸に分解されてエネル
ギー源として利用された。女性ホルモンによる脂肪動員
の促進と、筋肉への脂肪蓄積の増大の作用は、女子の体
内で基本的に認められる生理的調節である。さらに、女
性ホルモンは筋肉のリポたんぱくリパーゼを活性化し
て、血中脂肪の筋肉による取り込みを促し、筋肉に脂肪
を蓄積することを促進する。
Evidence supporting this theory has been obtained in experiments in which male rats were administered estrogen. After subcutaneous injection of estrogen for 5 days, treadmill running was applied for 3 hours, during which time liver and muscle glycogen consumption was examined over time. As a result, it was confirmed that in the estrogen administration group, glycogen consumption during exercise was remarkably low. This suggests that fat was actively used as an energy source during exercise. To confirm this, fat storage (perirenal adipose tissue weight), blood fatty acid levels, and fat mass in muscle were measured. As a result, it was found that administration of estrogen reduced stored fat, increased blood fatty acid levels, and increased muscle fat mass. Estrogen stimulated fat mobilization, indicating that muscles actively took up fatty acids in the blood and stored them as fat. Fat stored in muscle was broken down into fatty acids during exercise and used as an energy source. The effect of female hormones on promoting fat mobilization and increasing fat accumulation in muscle is a physiological regulation basically found in girls. In addition, female hormones activate muscle lipoprotein lipase, which promotes muscle fat uptake by blood and promotes muscle fat accumulation.

【0005】エネルギー代謝において、エネルギー源で
ある脂肪酸はグルコースと競合して利用されるので、脂
肪代謝を単独で取り上げることは不可能である。従来、
筋肉においては脂肪よりもグルコースが優先的にエネル
ギー化されると考えられてきた。また、筋肉がエネルギ
ーに利用する脂肪酸の主たる源は、脂肪組織から動員さ
れてくる血中脂肪酸が筋肉に取り込まれたものだという
考え方が一般的であった。しかし、それ以上に重要な脂
肪酸の供給源として、筋肉細胞に貯蔵される脂肪がある
ことが確かめられている。筋肉中の脂肪から動員される
脂肪酸は、筋肉中のグリコーゲンや血中のグルコースに
由来するグルコースよりも、運動のエネルギー源として
利用されやすいことを示唆する証拠が確認されている。
[0005] In energy metabolism, fatty acids, which are energy sources, are used in competition with glucose, so that it is impossible to take up fat metabolism alone. Conventionally,
It has been thought that glucose is preferentially energized over fat in muscle. Also, it was generally thought that the main source of fatty acids used by muscle for energy is that blood fatty acids mobilized from adipose tissue were taken into muscle. However, a more important source of fatty acids has been found to be fat stored in muscle cells. Evidence has been identified that suggests that fatty acids recruited from muscle fats are more likely to be used as an energy source for exercise than glucose derived from muscle glycogen and blood glucose.

【0006】すなわち、スポーツの競技力を高めるため
には、単純に筋肉にグリコーゲンが蓄積された条件だけ
でなく、筋肉に脂肪が蓄積されているというもう1つの
条件が整った中で、運動中のエネルギー代謝を運転する
ことが必要だと考えられる。筋肉に脂肪を蓄積するには
高脂肪食を摂取して血中にカイロミクロン脂肪を増や
し、筋肉のリポたんぱくリパーゼの作用でそれを分解し
て脂肪酸とし、筋肉中に取り込んで脂肪に合成すること
を促さなければならない。その合成促進に女性ホルモン
の投与が効果的である。
That is, in order to enhance the competitiveness of sports, not only the condition that glycogen is accumulated in muscles but also another condition that fat is accumulated in muscles is established. It is considered necessary to drive energy metabolism. To accumulate fat in muscle, eat a high-fat diet to increase chylomicron fat in the blood, break it down into fatty acids by the action of muscle lipoprotein lipase, take it into muscle and synthesize it into fat Must be encouraged. Administration of female hormones is effective in promoting its synthesis.

【0007】[0007]

【課題を解決するための手段】本発明は、女性ホルモン
の経口投与或いは皮下注射投与で、持久性運動能力向上
を図ることを目的としているが、女性ホルモンは一般的
な店舗では入手するのが困難であり、医師の診断が必要
です。又、女性ホルモンの投与には副作用があるため、
慎重に対処する必要があります。そこで、着目したのが
大豆の胚軸由来のイソフラボンです。イソフラボンは、
女性ホルモン(エストロゲン)の減少による女性の更年
期障害や骨粗しょう症の予防と治療そして毛髪活性に利
用され、効果が証明されている。イソフラボンは女性ホ
ルモン(エストロゲン)との構造類似性から大豆中のフ
ィトエストロゲンとして働く化学物質と考えられていま
す。daidzein、genisteinはエストロ
ゲンレセプターへ結合し、濃度に応じてエストロゲン作
用(アゴニスト)や抗エストロゲン作用(アンタゴニス
ト)を示します。代表的なエストロゲンである17βエ
ストラジオールがイソフラボノイドに両端の水酸基と平
板な環状構造が共通していることがわかります。この女
性ホルモン(エストロゲン)と構造的に類似している大
豆の胚軸由来のイソフラボン(フィトエストロゲン)
を、長距離ランニングのようにスタミナを要するスポー
ツを目的として、適量を経口摂取し、持久性運動能力向
上に役立てる。
SUMMARY OF THE INVENTION The object of the present invention is to improve endurance exercise ability by oral administration or subcutaneous injection of female hormones, but female hormones are generally available at general stores. Difficult and needs a doctor's diagnosis. In addition, because the administration of female hormones has side effects,
You need to be careful. We focused on isoflavones derived from the hypocotyl of soybeans. Isoflavones are
It has been proven to be effective in preventing and treating menopause and osteoporosis in women due to a decrease in female hormones (estrogens), and in hair activity. Isoflavones are thought to be chemicals that act as phytoestrogens in soybeans due to their structural similarity to the female hormone (estrogens). Daidzein and genestein bind to estrogen receptor and show estrogen action (agonist) or antiestrogen action (antagonist) depending on the concentration. It can be seen that 17β estradiol, a typical estrogen, has the same hydroxyl group at both ends and a flat cyclic structure as isoflavonoids. Isoflavones (phytoestrogens) from soybean hypocotyls that are structurally similar to this female hormone (estrogens)
For oral sports that require stamina, such as long-distance running, an appropriate amount is taken orally to improve endurance exercise ability.

【0008】[0008]

【発明の実施の形態】本発明の大豆の胚軸由来のイソフ
ラボンは、フィトエストロゲンを有効成分とする大豆食
品を、自体公知の食品あるいは食品成分、医薬担体また
は賦形剤と自体公知の方法で合して、持久性運動能力向
上食品とすることができます。用いる食品あるいは食品
成分は特に限定するものではなく、目的の長距離ランニ
ングのようにスタミナを要するスポーツに対して具体的
用途に応じて当業者が適宜選択できます。また、形態も
特に限定するものではなく、具体的用途に応じて、種々
の個体や形状にすることができます。本発明の持久性運
動能力向上の効果を発揮させるために、特に重要なこと
は、大豆の胚軸由来のイソフラボンの配合率で、一日の
摂取量を厳守して製品化することが大切です。体内摂取
の方法は、経口摂取によります。フィトエストロゲンを
有効成分とする大豆の胚軸由来のイソフラボンを経口摂
取する場合、成人に対して1日あたり、有効成分として
40mg〜500mg程度として、これを1日1〜数回
に分けて摂取することにより、副作用なく所望の効果を
発揮させることができます。
BEST MODE FOR CARRYING OUT THE INVENTION The isoflavone derived from the hypocotyl of soybean of the present invention can be prepared by converting a soybean food containing phytoestrogens as an active ingredient into a foodstuff known per se or a food ingredient, a pharmaceutical carrier or an excipient by a method known per se. In combination, it can be used as an endurance athletic ability food. The food or food ingredient to be used is not particularly limited, and can be appropriately selected by those skilled in the art according to the specific application for sports requiring stamina such as long-distance running. Also, the form is not particularly limited, and can be made into various individuals and shapes depending on the specific application. In order to exert the effect of the present invention to improve endurance athletic ability, it is particularly important that the product is formulated with strict adherence to the daily intake based on the mixing ratio of isoflavones derived from the hypocotyl of soybean. . The method of ingestion depends on oral intake. In the case of orally ingesting isoflavones derived from hypocotyls of soybeans containing phytoestrogens as an active ingredient, an adult is required to take about 40 mg to 500 mg of the active ingredient per day, and take it once or several times a day. By doing so, the desired effect can be achieved without side effects.

【0009】[0009]

【実施例】本発明の大豆の胚軸由来のイソフラボンを、
10粒中で200mg配合して製品化を試みた。形状は
打錠品で1粒300mgのタブレットとした。他の食品
成分として、ゴマミネラル、アミノ酸を配合した。この
ようにして製品化された製剤を、23才のデ杯選手のテ
ニスプレヤーに経口摂取することを依頼して、毎日10
粒程度を摂取してもらった。摂取後1週間が経過した時
点で、グリコーゲンの消費状態と脂肪の代謝状況を野外
での試合や練習後に測定した。大変激しい運動ではあっ
たが、摂取前と比較してグリコーゲンの消耗が肝臓、ヒ
ラメ筋、大腿筋で抑制されていることを確認した。ま
た、筋肉中の脂肪酸の蓄積も顕著に増大したことを確認
した。
EXAMPLE The isoflavone derived from the hypocotyl of soybean of the present invention was
Commercialization was attempted by blending 200 mg in 10 grains. The shape was a tablet product, and each tablet was 300 mg. Sesame mineral and amino acid were blended as other food ingredients. The 23-year-old tennis player who was a 23-year-old decup player was asked to orally ingest the product that had been commercialized in this manner.
I had them take about a grain. One week after ingestion, glycogen consumption and fat metabolism were measured after an outdoor game or practice. Although the exercise was very intense, it was confirmed that glycogen depletion was suppressed in the liver, soleus muscle and thigh muscle compared to before exercise. It was also confirmed that the accumulation of fatty acids in the muscle was significantly increased.

【0010】[0010]

【発明の効果】大豆の胚軸由来のイソフラボンの経口摂
取は、女性ホルモン(エストロゲン)との構造類似性か
らフィトエストロゲンとして働く化学物質と考えられ、
女性ホルモンが持久性運動のグリコーゲンの消費節約お
よび脂肪代謝促進作用に効果が確認された事実から、イ
ソフラボンの応用利用を実施した。その結果、期待どお
りの実績が確認された。
EFFECT OF THE INVENTION Oral ingestion of isoflavones derived from soybean hypocotyls is considered to be a chemical substance that acts as a phytoestrogen because of its structural similarity to the female hormone (estrogen).
Based on the fact that female hormones were effective in reducing glycogen consumption and promoting fat metabolism during endurance exercise, we applied isoflavones. As a result, the expected results were confirmed.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】大豆由来のイソフラボンによる運動時のグ
リコーゲン節約作用と脂肪代謝促進作用
1. Glycogen-saving effect and fat metabolism-promoting effect during exercise by isoflavones derived from soybean
JP28583199A 1999-09-01 1999-09-01 Energy metabolism in motion by isoflavone derived from soybean Pending JP2001072590A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP28583199A JP2001072590A (en) 1999-09-01 1999-09-01 Energy metabolism in motion by isoflavone derived from soybean

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28583199A JP2001072590A (en) 1999-09-01 1999-09-01 Energy metabolism in motion by isoflavone derived from soybean

Publications (1)

Publication Number Publication Date
JP2001072590A true JP2001072590A (en) 2001-03-21

Family

ID=17696654

Family Applications (1)

Application Number Title Priority Date Filing Date
JP28583199A Pending JP2001072590A (en) 1999-09-01 1999-09-01 Energy metabolism in motion by isoflavone derived from soybean

Country Status (1)

Country Link
JP (1) JP2001072590A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1388297A1 (en) * 2002-08-06 2004-02-11 Nestec S.A. Calcium absorption enhancer
JP2008037836A (en) * 2006-08-09 2008-02-21 Asahi Soft Drinks Co Ltd Food and drink for preventing/treating diabetes and hyperglycemia
JP2013017445A (en) * 2011-07-13 2013-01-31 Toyo Hakko:Kk Anti-fatigue composition
KR20150094261A (en) * 2014-02-11 2015-08-19 전남대학교산학협력단 Composition for Improving Exercise Ability comprising Extract from Canavalia gladiata

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1388297A1 (en) * 2002-08-06 2004-02-11 Nestec S.A. Calcium absorption enhancer
WO2004014155A3 (en) * 2002-08-06 2004-04-08 Nestec Sa Calcium absorption enhancer
EP2052630A1 (en) * 2002-08-06 2009-04-29 Nestec S.A. Calcium Absorption Enhancer
JP2008037836A (en) * 2006-08-09 2008-02-21 Asahi Soft Drinks Co Ltd Food and drink for preventing/treating diabetes and hyperglycemia
JP2013017445A (en) * 2011-07-13 2013-01-31 Toyo Hakko:Kk Anti-fatigue composition
KR20150094261A (en) * 2014-02-11 2015-08-19 전남대학교산학협력단 Composition for Improving Exercise Ability comprising Extract from Canavalia gladiata
KR101632698B1 (en) * 2014-02-11 2016-06-23 전남대학교산학협력단 Composition for Improving Exercise Ability comprising Extract from Canavalia gladiata

Similar Documents

Publication Publication Date Title
US6368617B1 (en) Dietary supplement
Campbell Synergistic use of higher-protein diets or nutritional supplements with resistance training to counter sarcopenia
US20070292493A1 (en) Pharmaceutical composition and method for the transdermal delivery of calcium
US20080317886A1 (en) Compositions for Preventing and Reducing Delayed Onset Muscle Soreness
JP4945710B2 (en) Use of ribose to prevent muscle cramps and muscle pain
TW200812503A (en) Compositions, methods and kits for enhancing weight loss while inhibiting loss of lean body mass
US7740878B2 (en) Use of betaine to enhance exercise performance
JPH11510048A (en) Two-phase preparation
JP2014532617A (en) Use of whey protein micelles to increase energy consumption and satiety
US6008252A (en) Method for increasing muscle mass in a mammal
KR100481379B1 (en) Food composition for lowering body fat content and improving body composition and method therefor
WO2001021182A1 (en) Physical strength enhancing agents and glycogen accumulation promoting agents
KR20070113460A (en) The health food composition for regulating weight
JP4484254B2 (en) Amino acid composition
WO2007143143A2 (en) Composition for enhancing muscle recovery
JP2001072590A (en) Energy metabolism in motion by isoflavone derived from soybean
CN102090453A (en) Weight-reducing and beautifying milk tea
JPH1036256A (en) Anti-osteoporosis composition
JP2006515879A (en) Method for improving nutrient utilization by mammals and compositions for use therein
Parsons et al. The effect of nutritional rehabilitation on whole body protein metabolism of children with cystic fibrosis
WO2006042909A1 (en) Nutrient supplement and use of the same
CN108719998A (en) An oral dietary supplement for the treatment of osteoarthritis
CN106036387A (en) Super chenopodium quinoa willd nutritional packet for promoting growth of children
JP5264269B2 (en) Sex hormone inducer and protein metabolism improvement and constitution improvement method using the same
JP2005263706A (en) Fat metabolism promotion composition and food and beverage containing the same